Insight Molecular Diagnostics (IMDX) Gains from Investment Securities (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Gains from Investment Securities of $3652.0 for Q1 2026, down 99.89% sequentially from $3.4 million in Q3 2025, and down 99.58% YoY from $879000.0 in Q1 2025.
Insight Molecular Diagnostics (IMDX) Gains from Investment Securities (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 12 years of Gains from Investment Securities data on file, last reported at $3652.0 in Q1 2026.
- Quarterly Gains from Investment Securities fell 99.58% year-over-year to $3652.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3652.0 (down 99.96% YoY) and the FY2025 annual result came in at $2.3 million, up 119.33% from the prior year.
- Gains from Investment Securities eased to $3652.0 in Q1 2026 per IMDX's latest filing, from $3.4 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $17.3 million in Q4 2022, with the low at -$9.6 million in Q4 2024.
- Average Gains from Investment Securities over 5 years is $933613.5, with a median of $177808.0 recorded in 2023.
- Year-over-year, Gains from Investment Securities plunged 21296.67% in 2022 and surged 2297.52% in 2024.
- Insight Molecular Diagnostics' Gains from Investment Securities stood at $17.3 million in 2022, then sank by 35.2% to $11.2 million in 2023, then sank by 185.74% to -$9.6 million in 2024, then soared by 135.22% to $3.4 million in 2025, then plunged by 99.89% to $3652.0 in 2026.
- Business Quant data shows IMDX's Gains from Investment Securities at $3652.0 in Q1 2026, $3.4 million in Q3 2025, and $20000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.92 Mn |
| Mar 31, 2026 | -5.92 Mn |
| Sep 30, 2025 | 3.38 Mn |
| Sep 30, 2025 | 3.38 Mn |
| Jun 30, 2025 | 2.80 Mn |
| Jun 30, 2025 | 2.80 Mn |
| Mar 31, 2025 | 879,000.00 |
| Mar 31, 2025 | 879,000.00 |
| Dec 31, 2024 | -9.59 Mn |
| Dec 31, 2024 | -9.59 Mn |
| Sep 30, 2024 | 7.14 Mn |
| Sep 30, 2024 | 7.14 Mn |
| Jun 30, 2024 | 270,000.00 |
| Jun 30, 2024 | 270,000.00 |
| Dec 31, 2023 | 11.19 Mn |
| Dec 31, 2023 | 11.19 Mn |
| Sep 30, 2023 | 297,808.00 |
| Sep 30, 2023 | 297,808.00 |
| Jun 30, 2023 | 177,808.00 |
| Jun 30, 2023 | 177,808.00 |